Biochemical parameters to assess choroid plexus dysfunction in Kearns-Sayre syndrome patients

Mitochondrion

Volumn 11, Issue 6, 2011, Pages 867-870

  Tondo, Mireia ^a   Málaga, Ignácio ^b   O'Callaghan, Mar ^a,e   Serrano, Mercedes ^a,e   Emperador, Sonia ^c,e   Ormazabal, Aida ^a,e   Ruiz Pesini, Eduardo ^c,e   Montoya, Julio ^c,e   Garcia Silva, Maria T ^d,e   Martin Hernandez, Elena ^d   Garcia Cazorla, Angels ^a,e   Pineda, Merce ^a,e   Artuch, Rafael ^a,e  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cerebrospinal fluid; Choroid plexus dysfunction; Homovanillic acid; Kearns Sayre syndrome; Selenium

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ALANINE; COPPER; GROWTH HORMONE; HOMOVANILLIC ACID; LACTIC ACID; MAGNESIUM; MITOCHONDRIAL DNA; PARATHYROID HORMONE; PROTEIN; SELENIUM; ZINC;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; ATAXIA; BRAIN REGION; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHOROID PLEXUS; CHOROID PLEXUS DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DELETION; HETEROPLASMY; HUMAN; KEARNS SAYRE SYNDROME; LACTATE BLOOD LEVEL; MEDULLA OBLONGATA; MESENCEPHALUS; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PUTAMEN; SCHOOL CHILD; SHORT STATURE; STRABISMUS; THYROID FUNCTION; TREMOR;

ADOLESCENT; CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; CHOROID PLEXUS; FEMALE; HOMOVANILLIC ACID; HUMANS; INFANT; KEARNS-SAYRE SYNDROME; MALE; PROTEINS; SELENIUM; TETRAHYDROFOLATES; YOUNG ADULT;

EID: 82755182851     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2011.06.009     Document Type: Article

References (19)

1. Allen R.J., DiMauro S., Coulter D.L., Papadimitriou A., Rothenberg S.P. Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate. Ann. Neurol. 1983, 13:679-681.
2. Burck R.F., Hill K.E., Motley K.M. Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J. Nutr. 2003, 133:1517S-1520S.
3. Chen J., Berry M.J. Selenium and selenoproteins in the brain and brain diseases. J. Neurochem. 2003, 86:1-12.
4. Davis C.D., Uthus E.O. Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. J. Nutr. 2003, 133:2907-2914.
5. Heitland P., Köster H.D. Biomonitoring of 37 trace elements in blood samples from inhabitants of northern Germany by ICP-MS. J. Trace Elem. Med. Biol. 2006, 20:253-262.
6. Hyland K., Lauren A., Arnold M.S. Value of lumbar puncture in the diagnosis of genetic metabolic encephalopathies. J. Child Neurol. 1999, 14(Suppl. 1):S9-S15.
7. Ormazabal A., García-Cazorla A., Fernández Y., Fernández-Alvarez E., Campistol J., Artuch R. HPLC with electrochemical and fluorescence detection procedures for the diagnosis of 302 inborn errors of biogenic amines and pterins. J. Neurosci. Methods 2005, 142:153-158.
8. Pineda M., Ormazábal A., López-Gallardo E., Nascimento A., Solano A., Herrero M.D., Vilaseca M.A., Briones P., Ibáñez L., Montoya J., Artuch R. Cerebral folate deficiency and leukoencephalopathy caused by mitochondrial DNA deletion. Ann. Neurol. 2006, 59:394-398.
9. Rasekh H.R., Davis M.D., Cooke L.W., Mazzio E.A., Reams R.R., Soliman K.F. The effect of selenium on the central dopaminergic system: a microdialysis study. Life Sci. 1997, 61:1029-1035.
10. Richardson R. More roles for selenoprotein P: local selenium storage and recycling protein in the brain. Biochem. J. 2005, 386:e5-e7.
11. Serrano M., Garcia-Silva M.T., Martin-Hernandez E., O'Callaghan M., Quijada P., Martinez-Aragón A., Ormazábal A., Blázquez A., Martín M.A., Briones P., López-Gallardo E., Ruiz-Pesini E., Montoya J., Artuch R., Pineda M. Kearns-Sayre syndrome: cerebral folate deficiency, MRI findings and new cerebrospinal fluid biochemical features. Mitochondrion 2010, 10:429-432.
12. Spector R. Nature and consequences of mammalian brain and CSF efflux transporters: four decades of progress. J. Neurochem. 2010, 112(1):13-23.
13. Spector R., Johanson C. Vectorial ligand transport through mammalian choroid plexus. Pharm. Res. 2010, 10:2054-2062.
14. Tanji K., Schon E.A., DiMauro A., Bonilla E. Kearns-Sayre syndrome: oncocytic transformation of choroids plexus epithelium. J. Neurol. Sci. 2000, 178:29-36.
15. Tondo M., Moreno J., Casado M., Brandi N., Sierra C., Vilaseca M.A., Ormazabal A., Artuch R. Selenium concentration in cerebrospinal fluid samples from a paediatric population. Neurochem. Res. 2010, 35(8):1290-1293.
16. Tsunoda M., Johnson V.J., Sharma R.P. Increase in dopamine metabolites in murine striatum after oral exposure to inorganic but not organic form of selenium. Arch. Environ. Contam. Toxicol. 2000, 39:32-37.
17. Wilber C.G. Toxicology of selenium: a review. Clin. Toxicol. 1980, 17(2):171-230.
18. Wolburg H., Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol. 2010, 119:75-88.
19. Zeviani M., Moraes C.T., DiMauro S., Nakase H., Bonilla E., Schon E.A., Rowland L.P. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988, 38:1339-1346.